构建转移性早期结肠癌患者的条件生存名录
Jue Luo1,2, Lei Zhao1,2, Shuyi Zhang1,2
1Department of Nursing Administration, Fudan University Shanghai Cancer Center, Shanghai, China.
Journal of gastrointestinal oncology
|November 12, 2025
概括
条件生存 (CS) 为转移性早期结肠癌 (mEO-CC) 提供了宝贵的预后见解. 新的诺米图预测CS,改善mEO-CC患者的预后准确性,并有助于后续规划.
科学领域:
- 在瘤学瘤学.
- 癌症预后 癌症预后
- 生存分析的分析.
背景情况:
- 条件生存 (CS) 提供了超越标准生存指标的预后信息.
- 在转移性早期结肠癌 (mEO-CC) 中进行CS预测的工具有限.
研究的目的:
- 在mEO-CC患者中评估CS.
- 开发用于预测CS的新型名ograms 在mEO-CC.
- 为了提高这个特定的患者群体的预后建模精度.
主要方法:
- 利用了SEER数据库 (2010-2019) 中的mEO-CC患者的数据.
- 定义CS作为诊断后的额外生存概率.
- 为预测条件整体存活率 (OS) 和癌症特异性存活率 (CSS) 构建了名图.
主要成果:
- 包括1988名mEO-CC患者;5年的OS和CSS随着时间的延续而增加.
- 确定了OS/CSS的独立风险因素,包括瘤的位置,分化,CEA水平和转移.
- 开发了具有良好的预测能力的有条件5年OS (AUC=0.765) 和CSS (AUC=0.761) 的名录.
结论:
- 对于mEO-CC患者的CS概率随着先前的生存率而增加.
- 时间调整的诺姆图为mEO-CC.提供了更可靠的预测预后.
- 这些估计可以改善风险沟通和后续战略.
更多相关视频
相关概念视频
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Kaplan-Meier Approach
547
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
547
Dosage Regimen Designs: Nomograms and Tabulations
166
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
166
Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542
Survival Curves
630
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
630
Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388


